Thursday, 16 August 2018

Novartis India ropes in Jawed Zia as new VC & MD

30 January 2018 | News

Zia has had a successful career working across pharmaceuticals, consumer health and devices.

Image credit- pharmaintelligence.com

Image credit- pharmaintelligence.com

Jawed Zia has been appointed as Vice Chairman and Managing Director at Novartis India, with effect from March 1, 2018. He is currently the head of pharmaceuticals. Zia has a wealth of experience gained in various geographies and functions in the healthcare sector across the globe

He will be succeeding Ranjit Shahani who will hold this position until February 28, 2018. Ranjit Shahani joined Novartis Indian board during 2002.

Zia had joined Ciba-Geigy in 1987, and has had a successful career working across pharmaceuticals, consumer health and devices. He has held positions of increasing responsibility in various functions of market research, brand, management, marketing management, division management and area management in Ireland, Saudi Arabia, Turkey, Singapore, Canada, Switzerland and now in India.

He set up and led the Alcon business in India from 2004 to 2012; and then moved to a regional role in Alcon in 2012 following which he jointed Novartis India in June 2014 as head pharmaceuticals.

Zia is a graduate in clinical pharmacology from All India Institute of Medical Sciences (AIIMS), New Delhi and holds an MBA from Trinity College, Dublin (Ireland).

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Will government's drug price caps trigger showdown with US?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls